Royal Bank Of Canada Acadia Pharmaceuticals Inc Call Options Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
352Shares Held
165MCall Options Held
709KPut Options Held
335K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.09 Billion9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$388 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$307 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$229 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$157 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $4.12B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...